Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial

Fig. 1

Study outline. At visit 1, rescue medications were prescribed, and diary cards were issued after informed consents were obtained; at visit 2, pre-ILAIT status was evaluated; at visits 3 to 5, subjects received intralymphatic immunotherapeutic allergen injection; at visits 6 to 7, post-ILAIT status was evaluated, respectively. ILAIT intralymphatic allergen-specific immunotherapy, HDM house dust mite

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us